Evidence map›Paper›PMID 26808198›Full record

ArticleProtein science : a publication of the Protein Society2016

Dynamics of the Tec-family tyrosine kinase SH3 domains.

Justin M Roberts, Sreya Tarafdar, Raji E Joseph, Amy H Andreotti, Thomas E Smithgall, John R Engen, Thomas E Wales

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Targeting the BMX in cancer: molecular mechanisms and emerging therapeutic strategies.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Dynamic regulatory features of the protein tyrosine kinases.Biochemical Society transactions · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Justin M RobertsDepartment of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts, 02115.
Sreya TarafdarDepartment of Microbiology & Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 15219.
Raji E JosephRoy J. Carver Department of Biochemistry, Biophysics & Molecular Biology, Iowa State University, Ames, Iowa, 50011.
Amy H AndreottiRoy J. Carver Department of Biochemistry, Biophysics & Molecular Biology, Iowa State University, Ames, Iowa, 50011.
Thomas E SmithgallDepartment of Microbiology & Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 15219.
John R EngenDepartment of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts, 02115.
Thomas E WalesDepartment of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts, 02115.
Northeastern University · USIowa State University · USUniversity of Pittsburgh · US

Funding

STRUCTURAL STUDIES OF A T CELL SPECIFIC TYROSINE KINASER01AI043957 · NIAID · IOWA STATE UNIVERSITY · PI AMY H ANDREOTTI, LESLIE JOAN BERG · 1999 to 2026
$9.5M
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule InhibitorsR01AI102724 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALVARADO, JOHN JEFF, SMITHGALL, THOMAS E. · 2013 to 2017
$1.9M
Extending the applications of hydrogen exchange mass spectrometryR01GM101135 · NIGMS · NORTHEASTERN UNIVERSITY · PI ENGEN, JOHN R · 2012 to 2015
$1.2M
NIAID NIH HHS AI043957NIAID NIH HHS AI102724NIAID NIH HHS R01 AI043957NIGMS NIH HHS R01 GM101135NIGMS NIH HHS R01-GM101135
6 · The paper itself

Abstract

The Src Homology 3 (SH3) domain is an important regulatory domain found in many signaling proteins. X-ray crystallography and NMR structures of SH3 domains are generally conserved but other studies indicate that protein flexibility and dynamics are not. We previously reported that based on hydrogen exchange mass spectrometry (HX MS) studies, there is variable flexibility and dynamics among the SH3 domains of the Src-family tyrosine kinases and related proteins. Here we have extended our studies to the SH3 domains of the Tec family tyrosine kinases (Itk, Btk, Tec, Txk, Bmx). The SH3 domains of members of this family augment the variety in dynamics observed in previous SH3 domains. Txk and Bmx SH3 were found to be highly dynamic in solution by HX MS and Bmx was unstructured by NMR. Itk and Btk SH3 underwent a clear EX1 cooperative unfolding event, which was localized using pepsin digestion and mass spectrometry after hydrogen exchange labeling. The unfolding was localized to peptide regions that had been previously identified in the Src-family and related protein SH3 domains, yet the kinetics of unfolding were not. Sequence alignment does not provide an easy explanation for the observed dynamics behavior, yet the similarity of location of EX1 unfolding suggests that higher-order structural properties may play a role. While the exact reason for such dynamics is not clear, such motions can be exploited in intra- and intermolecular binding assays of proteins containing the domains.

Indexed as

src Homology DomainsAmino Acid SequenceAnimalsBinding SitesDatabases, Nucleic AcidDeuterium Exchange MeasurementHumansMass SpectrometryMiceModels, MolecularProtein Structure, SecondaryProtein-Tyrosine KinasesProtein UnfoldingProtein-Tyrosine KinasesBruton's tyrosine kinase (Btk)EX1 kineticshydrogen exchange mass spectrometryIL-2 inducible T cell kinase (Itk)

Identifiers

PMID26808198
PMCPMC4941224
OpenAlexW2418602678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.